Lloyd TL - Search Results

1

Simultaneous quantification of seven active metabolites of roxifiban in human plasma by LC/MS/MS in the presence of an interfering displacer at millimolar concentrations.

Shi G, Lloyd TL, Sy SK, Jiao Q, Wernicki A, Mutlib A, Emm TA, Unger SE, Pieniaszek HJ Jr. Shi G, et al. Among authors: lloyd tl. J Pharm Biomed Anal. 2003 Apr 1;31(5):937-51. doi: 10.1016/s0731-7085(02)00675-1. J Pharm Biomed Anal. 2003. PMID: 12684106

2

High-speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma.

Deng Y, Wu JT, Lloyd TL, Chi CL, Olah TV, Unger SE. Deng Y, et al. Among authors: lloyd tl. Rapid Commun Mass Spectrom. 2002;16(11):1116-23. doi: 10.1002/rcm.688. Rapid Commun Mass Spectrom. 2002. PMID: 11992516

3

The science of laboratory and project management in regulated bioanalysis.

Unger S, Lloyd T, Tan M, Hou J, Wells E. Unger S, et al. Bioanalysis. 2014 May;6(10):1357-72. doi: 10.4155/bio.14.89. Bioanalysis. 2014. PMID: 24958120

4

Making methods rugged for regulated bioanalysis.

Unger S, Horvath T, Tan M, Zhou J, Lloyd T, McManus K, Wells E. Unger S, et al. Bioanalysis. 2015;7(7):833-52. doi: 10.4155/bio.14.317. Bioanalysis. 2015. PMID: 25932518 Review.

5

Determination of alosetron in human plasma or serum by high-performance liquid chromatography with robotic sample preparation.

Lloyd TL, Gupta SK, Gooding AE, Alianti JR. Lloyd TL, et al. J Chromatogr B Biomed Appl. 1996 Apr 12;678(2):261-7. doi: 10.1016/0378-4347(95)00491-2. J Chromatogr B Biomed Appl. 1996. PMID: 8738030

6

Robotic solid phase extraction and high performance liquid chromatographic analysis of ranitidine in serum or plasma.

Lloyd TL, Perschy TB, Gooding AE, Tomlinson JJ. Lloyd TL, et al. Biomed Chromatogr. 1992 Nov-Dec;6(6):311-6. doi: 10.1002/bmc.1130060613. Biomed Chromatogr. 1992. PMID: 1286291

7

Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients.

Gupta SK, Kunka RL, Metz A, Lloyd T, Rudolph G, Perel JM. Gupta SK, et al. J Clin Pharmacol. 1995 Feb;35(2):202-7. doi: 10.1002/j.1552-4604.1995.tb05012.x. J Clin Pharmacol. 1995. PMID: 7751433 Clinical Trial.

8

Automated high-performance liquid chromatographic analysis of (-)-2'-deoxy-3'-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems.

Hsyu PH, Lloyd TL. Hsyu PH, et al. Among authors: lloyd tl. J Chromatogr B Biomed Appl. 1994 May 13;655(2):253-9. doi: 10.1016/0378-4347(94)00114-6. J Chromatogr B Biomed Appl. 1994. PMID: 8081471

9

Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum.

Hsyu PH, Pritchard JF, Bozigian HP, Lloyd TL, Griffin RH, Shamburek R, Krishna G, Barr WH. Hsyu PH, et al. Among authors: lloyd tl. Pharm Res. 1994 Jan;11(1):156-9. doi: 10.1023/a:1018974501232. Pharm Res. 1994. PMID: 8140047 Clinical Trial.

10

Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.

Witherspoon SM, Emerson DL, Kerr BM, Lloyd TL, Dalton WS, Wissel PS. Witherspoon SM, et al. Among authors: lloyd tl. Clin Cancer Res. 1996 Jan;2(1):7-12. Clin Cancer Res. 1996. PMID: 9816083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters